Fibronectin (FN), epidermal growth factor-receptor (EGF-R) and heparin-binding epidermal growth factor-like (HB-EGF) urinary expressions and topical toxicity of adjuvant intravesical therapy for non muscle invasive bladder cancer (NMI-BC)
- Authors: Serretta, V; Alonge, V; Carità , G; Scalici Gesolfo, C; Caruso, S; Fiorentino, E; Russo, A; Torretta, F;
- Publication year: 2014
- Type: Proceedings
- Key words: bladder cancer, BCG, fibronectin, markers
- OA Link: http://hdl.handle.net/10447/94777
Abstract
NMI bladder cancer, EGF-R, intravesical therapy. fibronectin